AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice André, Mónica Arnedos, Alexander Spyridon Baras et al. · Cancer Discovery · 2017
Abstract The AACR Project GENIE is an international data-sharing consortium focused on generating an evidence base for precision cancer medicine by integrating clinical-grade cancer genomic data with clinical outcome data for tens of thousands of cancer patients treated at multiple institutions worldwide. In conjunction with the first public data release from approximately 19,000 samples, we describe the goals, structure, and data standards of the consortium and report conclusions from high-level analysis of the initial phase of genomic data. We also provide examples of the clinical utility of GENIE data, such as an estimate of clinical actionability across multiple cancer types (>30%) and prediction of accrual rates to the NCI-MATCH trial that accurately reflect recently reported actual match rates. The GENIE database is expected to grow to >100,000 samples within 5 years and should serve as a powerful tool for precision cancer medicine. Significance: The AACR Project GENIE aims to catalyze sharing of integrated genomic and clinical datasets across multiple institutions worldwide, and thereby enable precision cancer medicine research, including the identification of novel therapeutic targets, design of biomarker-driven clinical trials, and identification of genomic determinants of response to therapy. Cancer Discov; 7(8); 818–31. ©2017 AACR. See related commentary by Litchfield et al., p. 796. This article is highlighted in the In This Issue feature, p. 783
Cited by 1,941 works. doi:10.1158/2159-8290.cd-17-0151
Authors
- Fabrice André
- Mónica Arnedos
- Alexander Spyridon Baras
- José Baselga
- Philippe Lucien Bedard
- Michael F. Berger
- Mariska Bierkens
- Fabien M. Calvo
- Ethan G Cerami
- Debyani Chakravarty
- Kristen K. Dang
- Nancy E. Davidson
- Catherine Del Vecchio Fitz
- Semih Doğan
- Raymond N. DuBois
- Matthew D. Ducar
- P. Andrew Futreal
- Jianjiong Gao
- Francisco Moacir Pinheiro Garcia
- Stuart M. Gardos
References
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
- Comprehensive molecular portraits of human breast tumours
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- Comprehensive molecular characterization of human colon and rectal cancer
- Predicting the Future — Big Data, Machine Learning, and Clinical Medicine
- International network of cancer genome projects
- Discovery and saturation analysis of cancer genes across 21 tumour types
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer